LucidHealth names David Grau as CEO
Grau will become CEO on May 1, with Steve Corbeil moving to executive chairman of the board as part of a planned succession.

LucidHealth has appointed David Grau as chief executive officer, effective May 1, 2026. Steve Corbeil, who has served as CEO since 2023, will transition to executive chairman of the board.
Grau joined the Columbus, OH-based radiology services company in 2020 as chief strategy officer. He was named chief operating officer in 2024.
Before joining LucidHealth, Grau held senior leadership roles at McKesson Specialty and Anthelio Healthcare. LucidHealth said his experience includes strategy, operations, and growth execution in physician specialty services.
As chief operating officer, Grau led operational performance initiatives and worked across technology-related efforts, according to the company. LucidHealth said those efforts involved its network of more than 300 onsite and remote radiologists.
Corbeil will remain involved in strategic oversight and governance as executive chairman. He previously served as LucidHealth’s executive chairman from late 2019 through 2020 before becoming CEO.
LucidHealth serves more than 140 healthcare facilities across Ohio, West Virginia, Wisconsin, Illinois, Iowa, and Connecticut, according to the company.
In March, the company rebranded its teleradiology practice from LucidSolutions to Lucid Teleradiology. David West, MD, was appointed practice president of Lucid Teleradiology as part of that announcement.
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section

QT Imaging prices $10M public offering
QT Imaging Holdings priced a $10M underwritten public offering of common stock and pre-funded warrants. The breast imaging technology company plans to use proceeds for working capital and general corporate purposes.

EDAP, Telix explore PSMA PET and HIFU collaboration
EDAP TMS and Telix Pharmaceuticals signed a letter of intent to explore clinical research combining Focal One Robotic HIFU with Telix PSMA PET imaging agents in prostate cancer care.

UnitedHealthcare cites radiology costs in Maryland premium request
UnitedHealthcare is seeking an average 7.9% mid-year premium increase for some Maryland small-group plans. The insurer cited rising outpatient costs, including radiology, lab pathology, infusion, and radiation therapy.